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Purpose: To evaluate the clinical outcomes of laser in situ keratomileusis 
(LASIK) using a new approach for the calculation of the ablation profile based on 
wavefront vertexing from pupil plane to corneal. 
Methods: One hundred eyes of 50 patients (age, 21-41 years) with low and 
moderate myopia were enrolled in this prospective case series. All of them underwent 
topography-integrated wavefront-guided (TI-WFG) LASIK using the STAR S4IR 
excimer laser platform (Johnson & Johnson Vision). Visual, refractive, ocular 
aberrometric, ocular scattering index (OSI) and patient satisfaction outcomes were 
evaluated after a 90-day follow-up period. Astigmatic changes were evaluated by vector 
analysis. 
Results: A significant reduction in sphere and cylinder (p<0.001) was observed, 
with a significant improvement in uncorrected (UDVA) and corrected distance visual 
acuity (CDVA) (p<0.001). Postoperative spherical equivalent was within ±0.50 and 
±1.00 D in 91.1% (82/90) and 98.9% (89/90) of eyes, respectively. UDVA was 20/20 or 
better in 98.9% (89/90) of eyes. A total of 50.0% (45/90) of eyes gained 1 line of 
CDVA. Mean postoperative astigmatic correction index and angle of error were 
1.01±0.56 and 0.17±0.18º. Postoperative high order aberrometric coefficients were 
below 0.50 μm in 92.2% (83/90) of eyes. Mean postoperative OSI was 0.71±0.44. All 
patients referred to be satisfied with the final outcomes and would recommend the 













Conclusions: TI-WFG LASIK is a new approach for myopia and myopic 
astigmatism correction, with preservation of the ocular optical quality and high level of 
patient satisfaction associated 
Keywords: wavefront-guided LASIK, high order aberrations, topography-guided 














Wavefront-guided (WFG) laser in situ keratomileusis (LASIK) has 
demonstrated to be a safe and effective procedure for the correction of refractive errors 
for many years.1-3 This type of procedures has been shown to promote not only a visual 
improvement but also significant improvements in subjective functional vision and 
vision-related quality of life one year after surgery.4 In recent years, WFG LASIK has 
been enhanced due to several factors, most notably improvements in wavefront 
aberrometry and optimizations in femtosecond and excimer laser technologies.5 The 
introduction of high resolution wavefront aberrometers has led to an accurate and 
consistent characterization of the aberrometric pattern of any eye,6,7 including highly 
aberrated eyes, creating more advanced laser ablation profiles.8 In a recent randomized 
fellow eye controlled clinical trial,8 wavefront-optimized and high-resolution WFG 
LASIK have shown to provide excellent visual outcomes, nonetheless WFG treatments 
based on the high-resolution aberrometer offered superior results in some aspects, 
including refractive predictability and postoperative level of high order aberrations 
(HOAs). 
Topography-integrated wavefront-guided (TI-WFG) LASIK is a new approach 
for calculating the ablation profile based on the combination of topography and ocular 
wavefront aberrations obtained with a previously validated high-resolution topographer-
aberrometer.6,7 Since no clinical reports of this technique are available in the literature, 
the aim of the current study was to investigate the 3 month post-operative visual, 
refractive and optical quality outcomes in low to moderate myopic eyes with different 













Patients and methods 
 
Patients 
This prospective consecutive case series enrolled 100 eyes of 50 patients ranging 
in age from 21 to 41 years old screened for laser refractive surgery at Optilase Eye 
Clinic in Ireland. All cases presented low to moderate myopia with different levels of 
astigmatism and HOAs. All cases underwent TI-WFG LASIK using the STAR S4IR 
excimer laser combined with the iDesign system for treatment calculation (Johnson & 
Johnson Vision, Jacksonville, FL). Inclusion criteria for the study included myopic 
spherical refraction up to -6 D of sphere and manifest astigmatism below -2 D seeking 
for a laser refractive surgical solution to obtain spectacle independence. Exclusion 
criteria included patients with refractive errors out of the range defined in the inclusion 
criteria, active ocular pathology or media opacities, dry eye, unstable refraction for the 
last 12 months, residual corneal bed thickness below 300 μm, previous intraocular or 
corneal surgery, history of immunodeficiency or systemic connective tissue diseases, 
corneal alterations compatible with corneal ectatic disease, iris irregularities, and 
pregnancy or breastfeeding. The study received the approval of the Optilase Eye 
Medical Review Board. Patients were informed about the inclusion in the clinical study 
and gave informed consent to participate in it in accordance with the tenets of the 
Declaration of Helsinki.  
 
Examination protocol 
A complete preoperative ophthalmological examination was performed in all 
cases. Soft and rigid gas permeable contact lens wearers were asked to remove lenses at 












order to avoid the interference of any potential contact lens-related corneal warpage 
with our analysis. The preoperative exam included objective and manifest refraction, 
measurement of uncorrected (UDVA) and corrected distance visual acuity (CDVA), 
slit-lamp anterior segment examination, ultrasound pachymetry, corneal topography and 
ocular aberrometry measured with the iDesign 2.0 system (Johnson & Johnson Vision, 
Jacksonville, FL), applanation tonometry, and funduscopy. In the aberrometric analysis, 
the magnitude of the root mean square (RMS) for high order aberrations (HOAs), and 
the Zernike terms corresponding to primary vertical and horizontal coma, and primary 
spherical aberration (SA) for a pupil aperture of 6 mm were calculated and recorded.  
After surgery, a follow-up visit was performed the day after surgery to test 
UDVA and to assess the integrity of the corneal flap. The following clinical 
examinations were performed at 1 week, 1 month and 3 months postoperatively, 
including all of them UDVA and CDVA measurement, manifest refraction, 
biomicroscopic examination, corneal topographic analysis and ocular aberrometric 
analysis. In the last postoperative visit, an analysis of the ocular optical quality was also 
performed with a double-pass device that provides an estimation of light scattering [HD 
Analyzer, Optical Quality Analysis System (OQAS), Visiometrics SL]. Likewise, all 
patients were asked about their satisfaction with outcomes obtained after surgery using 
the following closed questions: Are you satisfied with the final outcomes?, Would you 
have the same surgical procedure again?, and Would you recommend this procedure to 
your friends and relatives?. 
 
Surgery 
All TI-WFG LASIK surgeries were performed by the same experienced surgeon 












Jacksonville, FL) was used to generate the corneal flaps, with an intended flap thickness 
of 110 microns (µm) and a flap diameter between 8.5 and 9.3 mm. Once the flap was 
generated, it was carefully lifted and the laser ablation carried out using the variable 
spot scanning excimer laser STAR S4IR (Johnson & Johnson Vision, Jacksonville, FL). 
The ablation profile was calculated considering the data obtained with the iDesign 2.0 
system. Treatments were programmed in all cases with a 6.0 to 6.7-mm optical zone and 
a total ablation zone of 8.0 mm, assuming a refractive target of emmetropia. Iris 
registration and eye tracking was used to ensure the centration of treatments during the 
ablation procedure. After ending the ablation, the stromal bed was irrigated with 
balanced saline solution and the flap repositioned. As standard postoperative treatment, 
a combination of dexamethasone and tobramycin was prescribed to be applied five 
times a day for one week, tapering the frequency during the two more following weeks. 
Also, patients were prescribed to use artificial tears at least every two hours the day 
after surgery and at least four times a day for one month. 
The TI-WFG ablation profiles are the result of integrating in the same device 
corneal topography and ocular aberrometry (iDesign 2.0 system). Specifically, as 
corneal topographic data is available in the new iDesign 2.0 software, the actual local 
curvature data from corneal topography is used instead of extrapolated values based on 
keratometry. For the ablation profile generation, the corneal surface information is used 
for two different purposes: calculation of the cosine effect and wavefront propagation. It 
should be considered that when the corneal vertex is not at the ablation center, the eye is 
seen as tilted from the ablation center. Thus, the cosine effect has a slightly uneven level 
of compensation to capture the actual energy loss. With TI-WFG LASIK, two 
components transforming the wavefront information from the pupil plane to the 












formula is used. For high-order aberrations, a keratometry-based spherocylindrical 
model was used to calculate each ray from pupil plane to spectacle plane with the 
previous version of iDesign, and thus not considering the local curvature variation of 
the human cornea (Table 1). With the new topo-integrated approach, each ray is 
propagated through the cornea based on the local curvature from the topographic map, 
being more accurate in capturing the local variation of the curvature of the cornea. 
 
Data analysis 
The commercially available software package SPSS was used to perform the 
statistical analyses with the data obtained in the clinical study (SPSS Version 20.0; IBM 
Corporation, Armonk, NY, USA). Normality of data samples was evaluated by means 
of the Kolmogorov-Smirnov test. When parametric analysis was possible, the Student t 
test for paired data was used for the analysis of differences between preoperative and 
postoperative visits, whereas the Wilcoxon ranked sum test was used for such purpose 
when the data samples were not normally distributed. The conventional sphero-
cylindrical refraction was transformed to Jackson crossed cylinder format to calculate 
M, J0, and J45 from the refractive data (S: sphere, C: cylinder, and α: cylinder axis) as 
the following: 
M= S+C/2                        J0= (-C/2) cos (2α)            J45= (-C/2) sin (2α) 
 
These numbers are the coordinates of a point in a 3-dimensional dioptric space 
(M, J0, J45). M is a spherical lens equal to the spherical equivalent (SE) of the given 













For all statistical tests, a p-value of less than 0.05 was considered as statistically 
significant.  
Regarding the analysis of astigmatic changes occurring after surgery, the Alpins 
vector method was used.10,11 According to this methodology, the vectors targeted 
induced astigmatism (TIA), defined as the vector of intended change in cylinder for 
each treatment, surgically induced astigmatism (SIA), defined as the vector of the real 
change achieved, and the difference vector (DV), defined as the additional astigmatic 
change that would enable the initial surgery to achieve its intended target, were 
calculated. Likewise, other parameters characterizing the astigmatic change with 
surgery were calculated, including the magnitude of error (ME) (difference between the 
magnitude of SIA and TIA), correction index (CI) (SIA/TIA) and the angle of error 




 A total of 100 eyes from 50 patients ranging in age from 21 to 41 years were 
included in the study. All eyes had myopia or myopic astigmatism. A total of 28 
(56.0%) patients were female and 22 (44.4%) were male. Mean ablation depth was 
60.88 µm (Standard deviation, SD: 18.03; median: 60.00; range: 30 to 103 µm) and 
mean flap diameter was 8.97 mm (Standard deviation, SD: 0.17; median: 9.00; range: 
8.50 to 9.30 mm). 
 
Visual and refractive outcomes 
 Table 2 summarizes the preoperative and postoperative visual and refractive data 












day after surgery (p<0.001), with a significant improvement associated in UDVA and 
CDVA (p<0.001). A significant additional improvement in UDVA and CDVA was 
observed during the remaining follow-up (p<0.001). Likewise, significant changes were 
found in refractive parameters during the rest of follow-up (p≤0.014), except for J0 
(p=0.071) and J45 (p=0.684). A total of 91.1% (82/90) and 98.9% (89/90) of eyes had a 
spherical equivalent within ±0.50 and ±1.00 D at 90 days after surgery, respectively 
(Figure 1). A total of 93.3% (84/90), 98.9% (89/90) and 100% (90/90) of eyes achieved 
UDVA of 20/16, 20/20 and 20/25 or better at 90 days after surgery, respectively (Figure 
1). All eyes achieved a postoperative CDVA of 20/20 or better at the end of the follow-
up. Regarding safety, no eye lost 2 lines or more of CDVA at 90 days after surgery and 
a total of 50.0% (45/90) of eyes gained 1 line (Figure 1). 
 
Vector analysis of astigmatic changes 
Table 3 displays the results of the vector analysis of astigmatic changes 
occurring during the follow-up after surgery. As shown, no significant changes in ME 
were detected during the follow-up, with a mean value of -0.04 D at 90 days 
postoperatively (p=0.005). Likewise, no significant changes during the follow-up were 
detected in SIA and CI at 90 days after surgery, with mean values of 0.65 D and 1.01, 
respectively. However, a small in magnitude but statistically significant increase in DV 
was observed (p=0.005). Concerning AE, a significant reduction was observed during 
the follow-up, with a mean value at 90 days after surgery of 0.17º. 
 
Ocular optical quality outcomes 
Table 4 provides a summary of the preoperative and postoperative ocular 












was observed in HOA RMS and spherical aberration Zernike term (p<0.001), with only 
7.8% (7/90) and 0% (0/90) of eyes showing postoperative values of more than 0.50 μm, 
respectively. Concerning coma, a small in magnitude but significant increase with 
surgery was found in the vertical (p<0.001) and horizontal (p=0.007) components of 
this type of aberration. Besides aberrations, the OQAS system was used to measure the 
ocular scattering index (OSI), obtaining a mean 90-day postoperative value of 0.71 (SD: 
0.44; median: 0.60; range: 0.30 to 3.60). 
 
Patient satisfaction outcomes 
 Concerning the questions about the satisfaction with the procedure, a total of 
44 (88.0%) patients answered them. All of them (100.0%, 44/44) answered "Yes" when 
were asked about the satisfaction with the final outcomes, the possibility of having the 
same surgical procedure again if necessary, and the recommendation of the procedure to 




 Different studies have been conducted to evaluate the clinical outcomes after 
LASIK surgery using different types of ablation profiles.12 Wavefront-optimized 
(WFO) ablation profiles have been designed to minimize the induction of spherical-like 
aberrations and to generate more physiological postoperative corneal profiles.1,8 
Likewise, ocular or total wavefront-guided ablations have been developed to optimize 
the ocular optics allowing a reduction of HOAs while minimizing the induction of new 
aberrations.1-3,8 This type of ablation profiles have been especially enhanced in recent 












ablation profiles, topography-guided and corneal wavefront-guided ablations have been 
developed to reduce corneal irregularity and optimize corneal shape modifications with 
or without considering corneal wavefront analysis, respectively.13,14 This type of laser 
treatments are especially useful in highly aberrated corneas.13,14 Recently, a new 
concept of laser ablation profile has been developed that combines topography and 
ocular wavefront data, TI-WFG LASIK. This concept is basically based on wavefront 
vertexing from pupil plane to corneal plane as the laser ablation is performed on the 
corneal surface. Likewise, the corneal vertex location as well as the topography are 
characterized and considered for the laser cosine effect compensation of the laser 
ablation. Thus, the wavefront-guided laser profile is optimized considering the shape 
peculiarities of the surface on which it is going to be applied. The aim of the current 
prospective study was to analyze and report the outcomes obtained with this new 
concept of ablation profile. To our knowledge, this is the first series evaluating the 
outcomes of TI-WFG LASIK. 
 Good visual and refractive outcomes were found in the current study, being 
consistent with those reported by previous authors evaluating the results of WFG 
LASIK with different laser platforms.1-3,8,15-18 At 90 days after surgery, a total of 91.1% 
and 98.9% of eyes had a spherical equivalent within ±0.50 and ±1.00 D, respectively. 
Other studies reporting the refractive outcomes of WFG LASIK using the same high 
resolution aberrometer (iDesign) and excimer laser (STAR S4IR) have found 
percentages of eyes with spherical equivalent within ±0.50 D of around 100%.2,3,16,17 In 
our series, a slight trend to overcorrection was found, with a 90-day postoperative mean 
spherical equivalent of +0.18 ± 0.31 D and a maximum postoperative value of spherical 
equivalent of +1.12 D. This may be due to the trend of overcorrecting slightly, as 












refractive correction accuracy with the implementation of the new ablation profile. In 
any case, this minimal trend to overcorrection can be modelled by linear regression and 
corrected if necessary. Concerning UDVA, a total of 93.3%, 98.9% and 100% of eyes 
achieved values of 20/16, 20/20 and 20/25 or better at 90 days after surgery, 
respectively. These findings are very consistent with those reported by previous authors 
using different type of WFG ablation profiles.2-4,15 In our series, the minimal trend to 
hyperopia did not have effect on UDVA as most of our patients were young adults and 
could compensate the minimal residual error with accommodation. The percentage of 
eyes with postoperative UDVA of 20/16 or better was higher with TI-WFG LASIK than 
those percentages reported by previous authors with WFG LASIK (74.14% Shetty et 
al,15 12% Duran et al2).  
 Concerning the correction of astigmatism, a vector analysis of changes occurring 
in manifest cylinder with surgery has been performed to provide a more complete 
evaluation of astigmatic changes, including magnitude and cylinder. Mean ME was 
remarkably close to zero at all postoperative visits, with no significant changes between 
them. This indicates that the surgical procedure evaluated was highly predictive in terms 
of correction of magnitude of cylinder. Likewise, the DV was in the range from 0.20 to 
0.26 D at all postoperative visits, with a minimal but statistically significant increase at 
the end of the follow-up. A mean value of CI of 1.01 was found at 90 days after surgery, 
confirming the excellent level of predictability of correction of the magnitude of 
astigmatism. Some authors have reported slightly lower values of CI after WFG 
LASIK, indicating a minimal trend to undercorrection.2,16,19,20 Schallhorn et al.20 found 
in a study enrolling 611 eyes with astigmatism of 2 D or more and undergoing WFG 
LASIK using the CustomVue platform that there was a minimal trend to 












0.14. Likewise, Durán et al2 found in another study evaluating the outcomes of WFG 
LASIK in myopic eyes with low to moderate levels of astigmatism that the mean CI at 
90 days postoperatively was 0.86. Besides the precision in the reduction of the 
magnitude of astigmatism, the laser procedure evaluated was also precise in terms of 
applying the astigmatic correction in the correct axis, with a mean AE at the end of 
follow-up of 0.17º. This mean value remarkably close to zero is lower than those mean 
values reported by other authors evaluating the astigmatic correction achieved with 
WFG LASIK using different excimer laser platforms.2,16,19-21  
 Besides all these changes, a significant improvement was observed in CDVA, 
with all eyes achieving a postoperative CDVA of 20/20 or better at the end of the 
follow-up and 50.0% of eyes gaining 1 line of CDVA. This confirms that the surgical 
procedure evaluated did not only correct the spherocylindrical error, but also it 
optimized the ocular optics. This percentage of gain of lines of CDVA is similar or 
somewhat lower than those reported by other authors in previous studies evaluating the 
outcomes of WFG LASIK.2-4,8,15 This is consistent with the outcomes obtained in terms 
of ocular aberrations and OSI. Specifically, small although statistically significant 
increases were observed in HOA RMS and spherical aberration Zernike term, with only 
7% and 0% of eyes showing postoperative values of more than 0.50 μm, respectively. 
Likewise, the change is primary coma components was minimal, maintaining the 
postoperative levels of this aberration within the normal range for a healthy 
population.22 Therefore, TI-WFG LASIK not only generates an ablation profile able to 
correct the spherocylindrical error accurately but also maintains the level of ocular 
aberration within a physiological range.22 Different studies evaluating the outcomes of 
WFG LASIK have demonstrated that WFG procedures can control the induction of high 












aberrations in significantly aberrated eyes.2,3,15-17 The sample evaluated in the current 
study only included healthy eyes with low levels of high order aberrations and therefore 
a minimal induction of such aberrations and maintaining a physiological aberrometric 
level was expected. Indeed, the mean value of OSI obtained postoperatively in the 
sample evaluated (0.71 ± 0.44), which is within the physiological range defined for the 
healthy human eye.23  
 According to all these outcomes, TI WFG-LASIK is safe and efficacious for the 
correction of myopic astigmatism, with an accurate correction of magnitude and axis of 
cylinder. Besides the nomogram factor and the inclusion of eyes with very low levels of 
high order aberrations, the slight trend to overcorrection of sphere observed in the 
current series as well as the relatively limited impact of the surgery on high order 
aberrations may be also influenced by other factors such as the creation of the flap. 
However, this seems to be a factor with minimal impact considering that the flap was 
created using the femtosecond technology that has been shown to generate planar flaps 
with minimal induction of aberrations.24 Hood et al25 demonstrated that femtosecond 
laser flap thickness in the range of 90-110 μm (as in our series) was not associated with 
poorer visual acuity or clinically significant induction of high order aberrations after 
uncomplicated customized myopic LASIK. 
 Finally, patient satisfaction outcomes were evaluated. All patients answering the 
subjective questionnaire indicated that they were satisfied with the final outcomes, 
would have the same surgical procedure again if necessary, and would recommend the 
procedure to their friends and relatives. This is consistent with the good visual, 
refractive and optical quality outcomes obtained. Chen and Manche4 reported that 
88.1% of patients undergoing WFG LASIK in a study enrolling 42 myopic patients 












and problems with corrective lenses subscales of the Refractive Status and Vision 
Profile questionnaire improving significantly. 
Several limitations should be acknowledged in this prospective study. One of 
them was not including a control group undergoing LASIK with an optimized ablation 
profile or any type of previously developed WFG ablation profile. Therefore, no 
consistent conclusions about the potential benefit of the technique evaluated over other 
types of treatments can be extracted, being the current study only focused on the 
evaluation of efficacy and safety of this new laser refractive surgery procedure. 
Likewise, the evaluation of the visual quality in terms of contrast sensitivity changes 
should have also been included as this evaluation is crucial for a better understanding of 
visual perception changes after any corneal refractive surgery procedure. Future 
comparative studies should be performed including an analysis of contrast sensitivity 
changes and analyzing the evolution of the outcomes in the long term. 
In conclusion, TI-WFG LASIK is a new approach for the laser surgical 
correction of myopia and myopic astigmatism, with preservation of the ocular optical 
quality and high level of patient satisfaction associated. This type of treatments provides 
a very predictable correction of astigmatism, with no trend to over or undercorrection. 
Future studies should be conducted to evaluate the results of this refractive surgery 
technique in the long term in a larger sample. Likewise, comparative studies of this new 
approach with no topography-optimized WFG LASIK and topography-guided LASIK 
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Figure 1.- Summary of the visual and refractive results using the standard graphs 
for reporting refractive surgery outcomes. (a) Uncorrected distance visual acuity. (b) 
Change in corrected distance visual acuity. (c) Spherical equivalent attempted versus 
achieved. (d) Spherical equivalent refractive accuracy. (e) Refractive astigmatism. (f) 

















Table 1.- Evolution from the WaveScan system to the iDesign 2.0 system from 
Johnson & Johnson Vision to calculate wavefront-guided ablation profiles. 
Abbreviation: K1, flattest keratometric reading; K2, steepest keratometric reading; cx 
and cy, Cartesian coordinates of the distance between pupil center and corneal vertex; 
Q, conic constant of adjustment; CT, corneal topography.   
Version Cosine Effect Wavefront Propagation 
WaveScan Uses K1, K2, not K2 axis 
Uses population mean of 0 for Q 
Does not use cx, cy (CT not available) 
Uses of K1, K2, K2 axis 
Uses population mean of -0.25 for Q 
Does not use cx, cy (CT not available) 
iDesign 1.x Uses K1, K2, K2 axis 
Uses population mean of -0.25 for Q 
Uses cx, cy from CT 
Uses K1, K2, K2 axis 
Uses population mean of -0.25 for Q 
Does not use cx, cy 
iDesign 2.0 Uses full topography, point by point 
Uses cx, cy from CT 
Uses full topography, point by point 













Table 2.- Summary of the preoperative and postoperative visual and refractive 




















1.00 (0.10 to 1.60) 
-0.07 (0.07) 
-0.08 (-0.18 to 0.22) 
-0.08 (0.07) 
-0.08 (-0.18 to 0.22) 
-0.09 (0.07) 
-0.08 (-0.18 to 0.10) 
-0.11 (0.06) 





-0.08 (-0.18 to 0.00) 
-0.09 (0.05) 
-0.08 (-0.18 to 0.10) 
-0.10 (0.05) 
-0.08 (-0.18 to 0.00) 
-0.11 (0.05) 
-0.08 (-0.18 to 0.00) 
-0.13 (0.05) 
-0.13 (-0.18 to 0.00) 
<0.001 
Sphere (D) -2.92 (1.35) 
-2.81 (-6.25 to 0.00) 
0.42 (0.28) 
0.37 (0.00 to 1.25) 
0.31 (0.27) 
0.25 (-0.50 to 1.00) 
0.36 (0.31) 
0.25 (-0.25 to 1.25) 
0.31 (0.32) 





-0.50 (-2.00 to 0.50) 
-0.19 (0.19) 
-0.25 (-1.00 to 0.25) 
-0.23 (0.21) 
-0.25 (-0.75 to 0.00) 
-0.21 (0.22) 
-0.25 (-1.00 to 0.00) 
-0.26 (0.23) 





-3.13 (-6.75 to -0.50) 
0.33 (0.28) 
0.25 (-0.25 to 1.00) 
0.20 (0.27) 
0.25 (-0.75 to 0.75) 
0.26 (0.29) 
0.25 (-0.38 to 1.00) 
0.18 (0.31) 





0.07 (-0.86 to 1.00) 
0.02 (0.11) 
0.00 (-0.35 to 0.50) 
0.05 (0.13) 
0.00 (-0.25 to 0.37) 
0.04 (0.12) 
0.00 (-0.46 to 0.35) 
0.06 (0.15) 





0.00 (-0.62 to 0.87) 
0.00 (0.06) 
0.00 (-0.16 to 0.25) 
0.00 (0.08) 
0.00 (-0.16 to 0.26) 
0.00 (0.08) 
0.00 (-0.20 to 0.32) 
-0.01 (0.07) 













 Table 3.- Ocular astigmatic changes analyzed by vector analysis. Abbreviations: 
TIA, targeted intended astigmatism; SIA, surgically induced astigmatism; DV, 






1 day 7 days 30 days 90 days p-value 
(1-90 
days) 
TIA (D) 0.69 (0.45) 
0.50 (0.25 to 2.00) 
0.69 (0.45) 
0.50 (0.25 to 2.00) 
0.69 (0.45) 
0.50 (0.25 to 2.00) 
0.69 (0.45) 





0.51 (0.03 to 2.21) 
0.67 (0.45) 
0.51 (0.00 to 2.04) 
0.65 (0.45) 
0.50 (0.07 to 2.00) 
0.65 (0.43) 
0.52 (0.00 to 1.99) 
0.205 
DV (D) 0.20 (0.19) 
0.25 (0.00 to 1.00) 
0.24 (0.22) 
0.25 (0.00 to 0.75) 
0.22 (0.23) 
0.25 (0.00 to 1.00) 
0.26 (0.24) 
0.25 (0.00 to 1.00) 
0.005 
 ME (D) 
 
0.02 (0.22) 
0.00 (-0.82 to 0.74) 
-0.02 (0.22) 
0.00 (-0.50 to 0.75) 
-0.03 (0.21) 
0.00 (-0.50 to 0.76) 
-0.04 (0.24) 





1.00 (0.07 to 2.96) 
1.03 (0.42) 
1.00 (0.00 to 2.44) 
0.99 (0.50) 
1.00 (0.28 to 4.05) 
1.01 (0.56) 
1.00 (0.00 to 4.19) 
0.835 
AE (º) 0.40 (0.44) 
0.33 (0.00 to 2.00) 
0.48 (0.54) 
0.31 (0.00 to 2.00) 
0.48 (0.66) 
0.33 (0.00 to 4.00) 
0.17 (0.18) 













Table 4.- Preoperative and postoperative aberrometric data. Abbreviations: 








Preop 30 days postop 90 days postop p-value (preop-90 
days) 
HOA RMS (µm) 
 
0.28 (0.08) 
0.27 (0.07 to 0.49) 
0.34 (0.09) 
0.33 (0.18 to 0.61) 
0.34 (0.11) 
0.35 (0.09 to 0.71) 
<0.001 
Vertical coma (µm) 
 
0.05 (0.15) 
0.07 (-0.30 to 0.38) 
-0.08 (0.18) 
-0.10 (-0.45 to 0.47) 
-0.12 (0.17) 
-0.14 (-0.47 to 0.49) 
<0.001 
Horizontal coma (µm) 
 
-0.01 (0.09) 
-0.02 (-0.24 to 0.28) 
-0.06 (0.12) 
-0.06 (-0.42 to 0.20) 
-0.05 (0.14) 
-0.07 (-0.41 to 0.35) 
0.007 
Spherical aberration (µm) 
 
0.07 (0.09) 
0.07 (-0.19 to 0.37) 
0.14 (0.10) 
0.13 (-0.22 to 0.38) 
0.13 (0.10) 
0.13 (-0.20 to 0.37) 
<0.001 
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